Processing .....please wait.. 
The article has been forwarded.... 
Dr Reddy's ties up with GlaxoSmithKline
Monday, 15 June 2009, 19:04 Hrs |
2 Comments
Mumbai: Pharmaceutical major major Dr Reddy's Laboratories Monday announced a partnership with Britain's GlaxoSmithKline (GSK) to develop and market select products across emerging markets outside India.
"Under the terms of the agreement, GSK will gain access to Dr. Reddy's rich and diverse portfolio and future pipeline of more than 100 branded pharmaceuticals in fast growing therapeutic segments such as cardiovascular, diabetes, oncology, gastroenterology and pain management," the company said in a regulatory statement.
G.V. Prasad, vice-chairman and chief executive officer of Dr Reddy's, said the tie-up would help the companies provide "affordable and innovative medicines to a much wider population".
The products will be manufactured by Dr. Reddy's and be licensed and supplied to GSK to market in emerging markets in Africa, the Middle East, Latin America and Asia Pacific, excluding India.
GSK will share revenues with Dr Reddy's as per agreed terms.
Abbas Hussein, president (emerging markets) of GlaxoSmithKline, said: "Together we will be able to deliver more medicines of value to more patients in these countries."
Source: IANS
"Under the terms of the agreement, GSK will gain access to Dr. Reddy's rich and diverse portfolio and future pipeline of more than 100 branded pharmaceuticals in fast growing therapeutic segments such as cardiovascular, diabetes, oncology, gastroenterology and pain management," the company said in a regulatory statement.
G.V. Prasad, vice-chairman and chief executive officer of Dr Reddy's, said the tie-up would help the companies provide "affordable and innovative medicines to a much wider population".
The products will be manufactured by Dr. Reddy's and be licensed and supplied to GSK to market in emerging markets in Africa, the Middle East, Latin America and Asia Pacific, excluding India.
GSK will share revenues with Dr Reddy's as per agreed terms.
Abbas Hussein, president (emerging markets) of GlaxoSmithKline, said: "Together we will be able to deliver more medicines of value to more patients in these countries."
Source: IANS
Don't Miss ( 1-5 of 20 )
Post your Comment
All form fields are required.
Write your comment now
Beautiful and dress selection, please go to Dresses
Sign Up for DailyDose and Read the Day's Highlights
Email:
 |
SiliconIndia:
About Us |
Contact Us |
Help |
Community rules |
Advertise with us |
Sitemap
News:
Technology |
Enterprise |
Tech Products |
Startups |
Finance |
Business |
Career |
Magazine |
Dailydose |
News archive
Career:
Jobs |
Companies |
Mentorship |
Videos |
Career blogs |
Training Institute |
Freshers
Online courses:
Web developer |
Java developer |
CCNA training |
SEO |
SAS |
SQL server 2005 |
J2EE
Education:
MBA |
MCA |
Engineering |
Overseas Education |
Internship
Life:
Jokes |
Bookstore |
Relocate |
Marketplace
Cities:
Startup |
Real estate |
Finance
Send your and help us continue to improve SiliconIndia
© 2012 SiliconIndia all rights reserved
© 2012 SiliconIndia all rights reserved